Published in Cancer Chemother Pharmacol on January 01, 1982
Radiation therapy in patients with unresectable hepatocellular carcinoma. Cancer Chemother Pharmacol (1992) 0.78
Hepatic irradiation in primary and metastatic liver cancer. Cancer Chemother Pharmacol (1989) 0.75
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys (2000) 7.50
Antiretroviral therapy in adults: updated recommendations of the International AIDS Society-USA Panel. JAMA (2000) 6.49
Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel. JAMA (1997) 6.35
Antiretroviral therapy for HIV infection in 1996. Recommendations of an international panel. International AIDS Society-USA. JAMA (1996) 5.29
More on managing metastatic choroidal tumors. Oncology (Williston Park) (1989) 5.12
HIV viral load markers in clinical practice. Nat Med (1996) 4.78
A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. The NIAID AIDS Clinical Trials Group. N Engl J Med (1992) 4.71
Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel. JAMA (1998) 4.61
CD4+ lymphocytes are an incomplete surrogate marker for clinical progression in persons with asymptomatic HIV infection taking zidovudine. Ann Intern Med (1993) 4.43
Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med (1984) 2.93
Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med (1988) 2.61
Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med (1986) 2.53
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial. N Engl J Med (1990) 2.29
The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22
Improving the outcomes of care for patients with human immunodeficiency virus infection. N Engl J Med (1996) 2.13
Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys (1993) 2.13
Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst (1996) 2.12
Representation of older patients in cancer treatment trials. Cancer (1994) 2.06
Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res (1993) 1.99
Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol (1995) 1.96
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys (1997) 1.93
Findings in psychiatric consultations with patients with acquired immune deficiency syndrome. Am J Psychiatry (1985) 1.90
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
The frequency of late reversibility in SPECT thallium-201 stress-redistribution studies. J Am Coll Cardiol (1990) 1.76
The National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06. N Engl J Med (1995) 1.74
Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg (1994) 1.72
Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys (1995) 1.71
Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys (1998) 1.71
Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys (1994) 1.70
Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats. Toxicol Appl Pharmacol (1986) 1.70
Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol (1997) 1.67
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. N Engl J Med (1994) 1.66
Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am (1998) 1.63
A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys (1991) 1.63
Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res (1987) 1.59
Retinoids in cancer therapy. J Clin Oncol (1992) 1.59
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst (1984) 1.59
RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys (1995) 1.57
High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1990) 1.56
Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. J Infect Dis (1994) 1.55
Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys (1999) 1.50
AIDS-associated non-Hodgkin's lymphoma in San Francisco. JAMA (1989) 1.48
Serological characterization of HTLV-III infection in AIDS and related disorders. J Infect Dis (1986) 1.47
Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103. J Clin Oncol (1993) 1.44
The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study. AIDS (1990) 1.44
Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol (1996) 1.43
HIV, HTLV-I, and CD4+ lymphocytes. Troubles in the relationship. JAMA (1994) 1.42
Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol (1988) 1.42
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42
Comorbid psychopathology in binge eating disorder: relation to eating disorder severity at baseline and following treatment. J Consult Clin Psychol (2000) 1.40
Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study. Int J Radiat Oncol Biol Phys (1988) 1.39
Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys (1994) 1.34
A Carboniferous insect gall: insight into early ecologic history of the Holometabola. Proc Natl Acad Sci U S A (1996) 1.34
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol (1989) 1.28
The clinical spectrum of the acquired immunodeficiency syndrome: implications for comprehensive patient care. Ann Intern Med (1985) 1.26
Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries. Asia Pac J Public Health (2004) 1.26
Desmoid tumors--treatment and prognosis. Radiology (1977) 1.26
Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev (1988) 1.25
The therapy of osteogenic sarcoma: current status and thoughts for the future. J Surg Oncol (1972) 1.24
Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer (1982) 1.24
Treatment of patients with acquired immunodeficiency syndrome and associated manifestations. JAMA (1987) 1.21
Thalamo-cortical processing of vibrissal information in the rat. I. Intracortical origins of surround but not centre-receptive fields of layer IV neurones in the rat S1 barrel field cortex. J Comp Neurol (1991) 1.21
Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery (1995) 1.21
An ultrastructural study of the development of radiation injury in the lung. Radiology (1966) 1.21
Primary hepatocellular cancer--present results and future prospects. Int J Radiat Oncol Biol Phys (1983) 1.20
Antibodies to human T-lymphotropic virus type III and development of the acquired immunodeficiency syndrome in homosexual men presenting with immune thrombocytopenia. Ann Intern Med (1986) 1.19
Preferences of homosexual men with AIDS for life-sustaining treatment. N Engl J Med (1986) 1.19
Intestinal infection with Mycobacterium avium in acquired immune deficiency syndrome (AIDS). Histological and clinical comparison with Whipple's disease. Dig Dis Sci (1985) 1.19
Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys (1983) 1.17
Kidney cell proliferation after unilateral nephrectomy as related to age. Cancer Res (1967) 1.16
Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res (1980) 1.16
Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer (1975) 1.15
Malignant tumors of the testis: analysis of treatment results and sites and causes of failure. Cancer (1977) 1.14
Antineoplastic activity of cannabinoids. J Natl Cancer Inst (1975) 1.14
Radiation retinopathy. Int J Radiat Oncol Biol Phys (1979) 1.12
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol (1980) 1.12
Accrual to clinical trials. J Natl Cancer Inst (1988) 1.09
1991 national survey of carcinoma of the breast by the Commission on Cancer. J Am Coll Surg (1994) 1.09
National Cancer Institute's evaluation of unconventional cancer treatments. J Natl Cancer Inst (1992) 1.08
Radiation response of artificial pulmonary metastases of the EMT6 tumor. Int J Radiat Oncol Biol Phys (1976) 1.08
Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res (1994) 1.08
Ethical dilemmas in caring for patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.08
High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys (1993) 1.07
Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys (1994) 1.07
Stereotaxic irradiation of brain tumors. Cancer (1990) 1.07
Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev (1980) 1.07
Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys (1979) 1.06
Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr (1973) 1.06
Predictors and impact of patients lost to follow-up in a long-term randomized trial of immediate versus deferred antiretroviral treatment. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Prognostic factors in adult soft-tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys (1997) 1.05
Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer (1977) 1.05
Tamoxifen: trials, tribulations, and trade-offs. J Natl Cancer Inst (1994) 1.05
Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721. Cancer Clin Trials (1981) 1.04
Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer (1976) 1.04
Time-dose relationships in the mouse esophagus. Radiology (1974) 1.03
Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys (1989) 1.03